Mohammad Sadegh Taghizadeh

Dr. Mohammad Sadegh Taghizadeh

Shiraz University, Shīrāz, Fārs, Iran
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in npj Science of Food
Verified
Journal Article
Open access
PDF file
AMArmin Mirzapour-Kouhdasht
Armin Mirzapour-Kouhdasht
DMDavid Julian McClements
David Julian McClements
Mohammad Sadegh TaghizadehMohammad Sadegh Taghizadeh
Mohammad Sadegh Taghizadeh
ANAli Niazi
Ali Niazi
Marco Garcia VaqueroMarco Garcia Vaquero
Marco Garcia Vaquero
Protein hydrolysis is a process used in the food industry to generate bioactive peptides of low molecular weight and with additional health benefits, such as antihypertensive, antidiabetic, and antioxidant properties that are often associated with their content on hydrophobic amino acids. This results in an increased bitterness of the products, making them less desirable for their use in food formulations. This review summarizes the main dietary sources of bitter bioactive peptides, including methods to determine their bitterness, such as the Q-values and electronic tongue; and the main factors and mechanisms underlying the bitterness of these compounds. The main strategies currently used to improve the taste and oral delivery of bioactive peptides are also discussed together with the main advantages and drawbacks of each technique. Debittering and masking techniques are reported in detail, including active carbon treatments, alcohol extraction, isoelectric precipitation, chromatographic methods, and additional hydrolytic processes. Other masking or blocking techniques, including the use of inhibitors, such as modified starch, taurine, glycine, and polyphosphates, as well as chemical modifications, such as amination, deamination, acetylation, or cross-linking were also discussed. The findings of this work highlight encapsulation as a highly effective method for masking the bitter taste and promoting the bioactivity of peptides compared to other traditional debittering and masking processes. In conclusion, the article suggests that advanced encapsulation technologies can serve as an effective means to mitigate the bitterness associated with bioactive peptides, while simultaneously preserving their biological activity, increasing their viability in the development of functional foods and pharmaceuticals.

10 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Mohammad Sadegh TaghizadehMohammad Sadegh Taghizadeh
Mohammad Sadegh Taghizadeh
ANAli Niazi
Ali Niazi
AMAli Moghadam
Ali Moghadam
AAAlireza Afsharifar
Alireza Afsharifar
Natural compounds are proper tools for inhibiting cancer cell proliferation. Hence, the search for these ligands of overexpressed receptors in breast cancer has been a competitive challenge recently and opens new avenues for drug discovery. In this research, we have investigated molecular interactions between natural products and overexpressed receptors in breast cancer using molecular docking and dynamic simulation approaches followed by extraction of the best ligand fromCitrus limettaand developing for nanoscale encapsulation composed of soy lecithin using a sonicator machine. The encapsulation process was confirmed by DLS and TEM analyses. Anticancer activity was also examined using MTT method. Among the investigated natural compounds, hesperidin was found to bind to specific targets with stronger binding energy. The molecular dynamics results indicated that the hesperidin-MCL-1 complex is very stable at 310.15 K for 200 ns. The RP-HPLC analysis revealed that the purity of extracted hesperidin was 98.8% with a yield of 1.72%. The results of DLS and TEM showed a strong interaction between hesperidin and lecithin with an entrapped efficiency of 92.02 ± 1.08%. Finally, the cytotoxicity effect of hesperidin was increased against the MDA-MB-231 cell line with an IC50value of 62.93 μg/mL after encapsulation, whereas no significant effect against the MCF10A cell line. We showed for the first time that hesperidin is a flexible and strong ligand for the MCL-1 receptor. Also, it has the in vitro ability to kill the MDA-MB-231 cell lines without having a significant effect on the MCF10A cell lines. Therefore, hesperidin could be used as a food ingredient to generate functional foods.

13 May 2019 in Journal of Texture Studies
Verified
Journal Article
Closed access
PDF file
AMArmin Mirzapour-Kouhdasht
Armin Mirzapour-Kouhdasht
FSForouzan Sabzipour
Forouzan Sabzipour
Mohammad Sadegh TaghizadehMohammad Sadegh Taghizadeh
Mohammad Sadegh Taghizadeh
MMMarzieh Moosavi‐Nasab
Marzieh Moosavi‐Nasab

14 May 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Mohammad Sadegh TaghizadehMohammad Sadegh Taghizadeh
Mohammad Sadegh Taghizadeh
MTMohsen Taherishirazi
Mohsen Taherishirazi
ANAli Niazi
Ali Niazi
AAAlireza Afsharifar
Alireza Afsharifar
AMAli Moghadam
Ali Moghadam
CDK9 (cyclin-dependent kinase 9) plays a significant role in numerous pathological conditions, such as HIV-1 infection and cancer. The interaction between CDK9 and cyclin T1 is crucial for maintaining the kinase’s active state. Therefore, targeting this protein-protein interaction offers a promising strategy for inhibiting CDK9. In this study, we aimed to design and characterize a library of mutant peptides based on the binding region of cyclin T1 to CDK9. Using Osprey software, a total of 7,776 mutant peptides were generated. After conducting a comprehensive analysis, three peptides, namely, mp3 (RAADVEGQRKRRE), mp20 (RAATVEGQRKRRE), and mp29 (RAADVEGQDKRRE), were identified as promising inhibitors that possess the ability to bind to CDK9 with high affinity and exhibit low free binding energy. These peptides exhibited favorable safety profiles and displayed promising dynamic behaviors. Notably, our findings revealed that the mp3 and mp29 peptides interacted with a conserved sequence in CDK9 (residues 60–66). In addition, by designing the structure of potential peptides in the plasmid vector pET28a (+), we have been able to pave the way for facilitating the process of their recombinant production in an Escherichia coli expression system in future studies. Predictions indicated good solubility upon overexpression, further supporting their potential for downstream applications. While these results demonstrate the promise of the designed peptides as blockers of CDK9 with high affinity, additional experimental studies are required to validate their biological activity and assess their selectivity. Such investigations will provide valuable insights into their therapeutic potential and pave the way for the future development of peptide-based inhibitors targeting the CDK9-cyclin T1 complex.

23 April 2024 in Food Bioscience
Verified
Journal Article
Closed access
ZSZahra Shahraki
Zahra Shahraki
Mohammad Sadegh TaghizadehMohammad Sadegh Taghizadeh
Mohammad Sadegh Taghizadeh
ANAli Niazi
Ali Niazi
VRVahid Rowshan
Vahid Rowshan
AMAli Moghadam
Ali Moghadam

2 March 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAli Moghadam
Ali Moghadam
EFEisa Foroozan
Eisa Foroozan
ATAhmad Tahmasebi
Ahmad Tahmasebi
Mohammad Sadegh TaghizadehMohammad Sadegh Taghizadeh
Mohammad Sadegh Taghizadeh
MBMohammad Bolhassani
Mohammad Bolhassani
MJMorteza Jafari
Morteza Jafari
Medicinal plants contain valuable compounds that have attracted worldwide interest for their use in the production of natural drugs. The presence of compounds such as rosmarinic acid, carnosic acid, and carnosol in Rosmarinus officinalis has made it a plant with unique therapeutic effects. The identification and regulation of the biosynthetic pathways and genes will enable the large-scale production of these compounds. Hence, we studied the correlation between the genes involved in biosynthesis of the secondary metabolites in R. officinalis using proteomics and metabolomics data by WGCNA. We identified three modules as having the highest potential for the metabolite engineering. Moreover, the hub genes highly connected to particular modules, TFs, PKs, and transporters were identified. The TFs of MYB, C3H, HB, and C2H2 were the most likely candidates associated with the target metabolic pathways. The results indicated that the hub genes including Copalyl diphosphate synthase (CDS), Phenylalanine ammonia lyase (PAL), Cineole synthase (CIN), Rosmarinic acid synthase (RAS), Tyrosine aminotransferase (TAT), Cinnamate 4-hydroxylase (C4H), and MYB58 are responsible for biosynthesis of important secondary metabolites. Thus, we confirmed these results using qRT-PCR after treating R. officinalis seedlings with methyl jasmonate. These candidate genes may be employed for genetic and metabolic engineering research to increase R. officinalis metabolite production.